Table 2:
Approximate Population-Attributable Risk Estimates for Genetic Disorders and Incidence in African Americans
Genetic Variant | Population Prevalence | ESKD Population Attributable Risk % |
---|---|---|
APOL1 High Risk ESKD in general population26 | 13% | 19% |
Diabetic Kidney Disease27 | 15% | 13% |
High Risk APOL1 and Biopsy-proven FSGS-ESKD18 | 13% | 67% |
High Risk APOL1 and Biopsy-proven Hypertensive ESKD9 | 13% | 45% |
High Risk APOL1 and HIVAN-ESKD | 13% | 78.4% |
Sickle Cell Trait12 | 8% | 9.9% |
NPHS1 T233A58 | - | 1.1% |
NPHS1 Y1174H (protection)58 | - | 2.43% |
NPHS1 H800R (protection)58 | - | 4.56% |